ZATECKY, Jan, Oldřich COUFAL, Miloš HOLÁNEK, Otakar KUBALA, Marketa KEPICOVA, Jiri GATEK, Milan LERCH and Matus PETEJA. Level I axillary dissection in patients with breast cancer and tumor-involved sentinel lymph node after NAC is not sufficient for adequate nodal staging. TURKISH JOURNAL OF SURGERY. TURKEY: TURKISH SURGICAL ASSOC, 2023, vol. 39, No 1, p. 1-6. ISSN 2564-6850. Available from: https://dx.doi.org/10.47717/turkjsurg.2023.5984.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Level I axillary dissection in patients with breast cancer and tumor-involved sentinel lymph node after NAC is not sufficient for adequate nodal staging
Authors ZATECKY, Jan (203 Czech Republic), Oldřich COUFAL (203 Czech Republic, belonging to the institution), Miloš HOLÁNEK (203 Czech Republic, belonging to the institution), Otakar KUBALA (203 Czech Republic), Marketa KEPICOVA (203 Czech Republic), Jiri GATEK (203 Czech Republic), Milan LERCH (203 Czech Republic) and Matus PETEJA (203 Czech Republic).
Edition TURKISH JOURNAL OF SURGERY, TURKEY, TURKISH SURGICAL ASSOC, 2023, 2564-6850.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30204 Oncology
Country of publisher Turkey
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 0.600 in 2022
RIV identification code RIV/00216224:14110/23:00133908
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.47717/turkjsurg.2023.5984
UT WoS 000946256700003
Keywords in English Breast cancer; sentinel lymph node biopsy; neoadjuvant chemotherapy; axillary dissection; level I axillary dissection
Tags 14110811, 14110813, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 5/4/2024 09:39.
Abstract
Objective: The purpose of the study was to investigate the oncological sufficiency of level I axillary dissection for adequate histological nodal staging (ypN) in patients with breast cancer and tumor-involved sentinel lymph node (SLN) after neoadjuvant chemotherapy (NAC).
PrintDisplayed: 3/9/2024 20:22